These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 25099575)

  • 41. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.
    Obermeier K; Sachsenweger J; Friedl TW; Pospiech H; Winqvist R; Wiesmüller L
    Oncogene; 2016 Jul; 35(29):3796-806. PubMed ID: 26640152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PALB2 mutations in European familial pancreatic cancer families.
    Slater EP; Langer P; Niemczyk E; Strauch K; Butler J; Habbe N; Neoptolemos JP; Greenhalf W; Bartsch DK
    Clin Genet; 2010 Nov; 78(5):490-4. PubMed ID: 20412113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.
    Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M
    Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutation analysis of PALB2 gene in French breast cancer families.
    Damiola F; Schultz I; Barjhoux L; Sornin V; Dondon MG; Eon-Marchais S; Marcou M; ; Caron O; Gauthier-Villars M; de Pauw A; Luporsi E; Berthet P; Delnatte C; Bonadona V; Maugard C; Pujol P; Lasset C; Longy M; Bignon YJ; Fricker JP; Andrieu N; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Muller D
    Breast Cancer Res Treat; 2015 Dec; 154(3):463-71. PubMed ID: 26564480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.
    Ghiorzo P; Pensotti V; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bonelli L; Borgonovo G; Bruno W; Gozza A; Gargiulo S; Mastracci L; Nasti S; Palmieri G; Papadia F; Pastorino L; Russo A; Savarino V; Varesco L; Bernard L; Bianchi Scarrà G;
    Fam Cancer; 2012 Mar; 11(1):41-7. PubMed ID: 21989927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PALB2 sequence variants in young South African breast cancer patients.
    Sluiter M; Mew S; van Rensburg EJ
    Fam Cancer; 2009; 8(4):347-53. PubMed ID: 19333784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma.
    Sabbaghian N; Kyle R; Hao A; Hogg D; Tischkowitz M
    Fam Cancer; 2011 Jun; 10(2):315-7. PubMed ID: 21153565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast-cancer risk in families with mutations in PALB2.
    Lee AS; Ang P
    N Engl J Med; 2014 Oct; 371(17):1650-1. PubMed ID: 25337758
    [No Abstract]   [Full Text] [Related]  

  • 49. Breast-cancer risk in families with mutations in PALB2.
    Sopik V; Narod SA
    N Engl J Med; 2014 Oct; 371(17):1650. PubMed ID: 25337757
    [No Abstract]   [Full Text] [Related]  

  • 50. Breast-cancer risk in families with mutations in PALB2.
    Antoniou AC; Foulkes WD; Tischkowitz M
    N Engl J Med; 2014 Oct; 371(17):1651-2. PubMed ID: 25337756
    [No Abstract]   [Full Text] [Related]  

  • 51. Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
    Wu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
    Breast Cancer Res Treat; 2020 Feb; 179(3):605-614. PubMed ID: 31768816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
    Fernandes PH; Saam J; Peterson J; Hughes E; Kaldate R; Cummings S; Theisen A; Chen S; Trost J; Roa BB
    Cancer; 2014 Apr; 120(7):963-7. PubMed ID: 24415441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.
    Pylkäs K; Erkko H; Nikkilä J; Sólyom S; Winqvist R
    BMC Cancer; 2008 May; 8():146. PubMed ID: 18501021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo.
    Catucci I; Peterlongo P; Ciceri S; Colombo M; Pasquini G; Barile M; Bonanni B; Verderio P; Pizzamiglio S; Foglia C; Falanga A; Marchetti M; Galastri L; Bianchi T; Corna C; Ravagnani F; Bernard L; Fortuzzi S; Sardella D; Scuvera G; Peissel B; Manoukian S; Tondini C; Radice P
    Genet Med; 2014 Sep; 16(9):688-94. PubMed ID: 24556926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
    Janatova M; Kleibl Z; Stribrna J; Panczak A; Vesela K; Zimovjanova M; Kleiblova P; Dundr P; Soukupova J; Pohlreich P
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2323-32. PubMed ID: 24136930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Germline mutations in PALB2 in African-American breast cancer cases.
    Ding YC; Steele L; Chu LH; Kelley K; Davis H; John EM; Tomlinson GE; Neuhausen SL
    Breast Cancer Res Treat; 2011 Feb; 126(1):227-30. PubMed ID: 21113654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer.
    Guénard F; Pedneault CS; Ouellette G; Labrie Y; Simard J; ; Durocher F
    Genet Test Mol Biomarkers; 2010 Aug; 14(4):515-26. PubMed ID: 20722467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.
    Foulkes WD; Ghadirian P; Akbari MR; Hamel N; Giroux S; Sabbaghian N; Darnel A; Royer R; Poll A; Fafard E; Robidoux A; Martin G; Bismar TA; Tischkowitz M; Rousseau F; Narod SA
    Breast Cancer Res; 2007; 9(6):R83. PubMed ID: 18053174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China.
    Deng M; Chen HH; Zhu X; Luo M; Zhang K; Xu CJ; Hu KM; Cheng P; Zhou JJ; Zheng S; Chen YD
    Int J Cancer; 2019 Sep; 145(6):1517-1528. PubMed ID: 30720863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
    Fewings E; Larionov A; Redman J; Goldgraben MA; Scarth J; Richardson S; Brewer C; Davidson R; Ellis I; Evans DG; Halliday D; Izatt L; Marks P; McConnell V; Verbist L; Mayes R; Clark GR; Hadfield J; Chin SF; Teixeira MR; Giger OT; Hardwick R; di Pietro M; O'Donovan M; Pharoah P; Caldas C; Fitzgerald RC; Tischkowitz M
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):489-498. PubMed ID: 29706558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.